Cite
Efficacy and safety of ivermectin in patients with mild and moderate COVID-19: A randomized controlled trial.
MLA
Malektojari, Alireza, et al. “Efficacy and Safety of Ivermectin in Patients with Mild and Moderate COVID-19: A Randomized Controlled Trial.” Asian Pacific Journal of Tropical Medicine, vol. 16, no. 1, Jan. 2023, pp. 3–8. EBSCOhost, https://doi.org/10.4103/1995-7645.364007.
APA
Malektojari, A., Ghazizadeh, S., Ersi, M. H., Brahimi, E., Hassanipour, S., Fathalipour, M., & Hassaniazad, M. (2023). Efficacy and safety of ivermectin in patients with mild and moderate COVID-19: A randomized controlled trial. Asian Pacific Journal of Tropical Medicine, 16(1), 3–8. https://doi.org/10.4103/1995-7645.364007
Chicago
Malektojari, Alireza, Sara Ghazizadeh, Mohammad Hamed Ersi, Elham Brahimi, Soheil Hassanipour, Mohammad Fathalipour, and Mehdi Hassaniazad. 2023. “Efficacy and Safety of Ivermectin in Patients with Mild and Moderate COVID-19: A Randomized Controlled Trial.” Asian Pacific Journal of Tropical Medicine 16 (1): 3–8. doi:10.4103/1995-7645.364007.